Protalix BioTherapeutics to Participate in the 18th Annual WORLDSymposium™ 2022
- Thursday, February 3, 2022, 7:10
- PR Newswire
- Add a comment
CARMIEL, Israel, Feb. 3, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…
About the Author
admin has written 21776 stories on this site.